6550 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Polaris Group engages in the research and development of biotechnology drugs. Its business activities include exploration and confirmation of new drug targets, design and improvement of large and small molecule new drugs, planning and execution of clinical trials, and manufacture and quality control of pharmaceutical drugs. It offers cancer treatment drugs, and contract development and manufacturing organization services for biopharmaceutical industries. The company was founded on February 9, 2006 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6550 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company